SCHEMBL14601092

SCHEMBL14601092

CC(=O)OCC1OC(S)C(OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.58
THRB P10828 1/20 0.58
HSD17B10 Q99714 1/20 0.58
TSHR P16473 1/20 0.57
NR3C1 P04150 1/20 0.57
FYN P06241 1/20 0.57
ADRA2A P08913 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
ADRA2B P18089 1/20 0.57
DRD4 P21917 1/20 0.57
DRD3 P35462 1/20 0.57
CA2 P00918 13/20 0.56
CA12 O43570 12/20 0.56
CA1 P00915 12/20 0.56
CA9 Q16790 7/20 0.56
PKM P14618 1/20 0.51
PTPN1 P18031 1/20 0.51
CA4 P22748 7/20 0.49
CA5A P35218 7/20 0.49
CA7 P43166 7/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3556856 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1
SCHEMBL1582429 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1
SCHEMBL1582644 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1
SCHEMBL13576463 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1
SCHEMBL2353098 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1
SCHEMBL10982935 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1
SCHEMBL1582750 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1
SCHEMBL12716359 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1
SCHEMBL9887803 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1
SCHEMBL1582130 1.00 CYP2D6 (0.58) CYP2D6THRBHSD17B10TSHRNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021380-A1 Novel drug delivery compositions WIEBE LEONARD 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021380-A1 Novel drug delivery compositions NME4, NUDT1, NT5C2 CYP2D6 4084/4885THRB 3806/4885HSD17B10 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.